Dr Michael Levin is a neuroscientist unravelling the mysteries of nerve degeneration in Multiple Sclerosis patients.

He's also Saskatchewan's inaugural MS Clinical Research Chair, whose team recently won a New Frontiers in Research Fund award.

"In my lifetime, there's been a dramatic change in how we treat MS," said Levin. "There's a lot of hope when people come into the clinic."

But after taking steroids for a number of years, many MS patients still relapse.

"It's this kind of slow degenerative kind of nickel and diming of people's function that we would really like to nip in the bud," said Levin.

His task now is to find a drug that re-shapes a key protein involved with nerve degeneration, sending that protein back into its normal position.

In this episode, hear why this could be a game-changer for MS patients across Saskatchewan and the world.